Released Nov 10, 2020, after the close
10-Q filed Nov 10, 2020, 41 days after period end · 0001636422-20-000084
Q3 2020 · 10-Q
Revenue$47.19M$47.19M +19.7% vs Q3 2019+9.1% vs Q2 2020
Net Income-$27.33M-$27.33M N/M vs Q3 2019N/M vs Q2 2020
EPS Diluted-$0.68-$0.68 N/M vs Q3 2019N/M vs Q2 2020
Operating Income-$23,458,000N/M
Operating Cash Flowderived-$4,487,000N/M
Free Cash Flowderived-$5,018,000N/M
Margins · derived
Operating margin-49.7%+2.9 pt vs Q3 2019
Net margin-57.9%−3.6 pt vs Q3 2019
What the release said
The release
Same quarter
| Metric | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|
| Revenue | $47.19M | $39.42M | $32.87M |
| Net Income | -$27.33M | -$21.42M | -$16.88M |
| EPS Diluted | -$0.68 | -$1.40 | -$3.71 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR